Preventive effects of flavonoids on alloxan-induced diabetes mellitus in rats

Acta Veterinaria Brno

Volumn 77, Issue 2, 2008, Pages 175-182

  Lukacinova A ^a   Mojzis J ^a   Benacka R ^a   Keller, J ^a   Maguth, T ^a   Kurila, P ^a   Vasko L ^b   Racz O ^a   Ništiar, František ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b UNIVERSITY OF VETERINARY MEDICINE   (Slovakia)

Author keywords

Alloxan induced diabetes; Chrysin; Flavonoids; Oxidative stress; Preventive effect; Quercetin

Indexed keywords

ANIMALIA; RATTUS;

EID: 48249137728     PISSN: 00017213     EISSN: None     Source Type: Journal    
DOI: 10.2754/avb200877020175     Document Type: Article

References (36)

1. ANJANEYULU M, CHOPRA K 2004: Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 31: 244-248
2. BARTOŠÍKOVÁ L, NEČAS J, SUCHÝ V, KUBÍNOVÁ R, VESELÁ D, BENEŠ L, BARTOŠÍ K T, ILLEK J, ŠALPLACHTA J, KLUSÁKOVÁ J, BARTOŠOVÁ L, STRNADOVÁ V, FRÁŇA P, FRÁŇOVÁ J 2003a: Monitoring of antioxidative effect of morine in alloxan-induced diabetes mellitus in the laboratory rat. Acta Vet Brno 72: 191-200
3. BARTOŠÍKOVÁ L, NEČAS J, SUCHÝ V, KUBÍNOVÁ R, VESELÁ D, BENEŠ L, ILLEK J, ŠALPLACHTA J, FLORIAN T, FRYDRYCH M, KLUSÁKOVÁ J, BARTOŠÍK T, FRÁŇA L, FRÁŇA P, DZÚROVÁ J 2003b: Antioxidative effect of morine in ischemia-reperfusion of kidneys in the laboratory rat. Acta Vet Brno 72: 87-94
4. BENTSÁTH A, RUSZNYÁK S, SZENT-GYÖRGYI A 1936: Vitamin nature of flavones. Nature 138: 798
5. BLÁHA L, KOPP R, ŠIMKOVÁ K, MAREŠ J 2004: Oxidative stress biomarkers are modulated in silver carp (Hypophthalmichthys molitrix Val.) exposed to microcystin-producing cyanobacterial water bloom. Acta Vet Brno 73: 477-482
6. CHEN JW, ZHU ZQ, HU TX, ZHU DY 2002: Structure-activity relationship of natural flavonoids in hydroxyl radical-scavenging effects. Acta Pharmacol Sin 23: 667-672
7. COSKUN O, KANTER M, KORKMAZ A, OTER S 2005: Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol Res 51: 117-123
8. DE BOER VCJ, DIHAL AA, VAN DER WOUDE H, ARTS ICW, WOLFFRAM S, ALINK GM, RIETJENS IMCM, KEIJER J, HOLLMAN PCH 2005: Tissue distribution of quercetin in rats and pigs. J Nutr 135: 1718-1725
9. DENE BA, MARITIM AC, SANDERS RA, WATKINS JB 2005: Effects of antioxidant treatment on normal and diabetic rat retinal enzyme activities. J Ocular Pharmacol Ther 21: 28-35
10. DIAS AS, PORAWSKI M, ALONSO M, MARRONI N, COLLADO PS, GONZÁLEZ-GALLEGO J 2005: Quercetin decreases oxidative stress, NF-κB activation, and iNOS overexpression in liver of streptozotocin- induced diabetic rats. J Nutr 135: 2299-2304
11. DOUBEK J, VOLNÝ T, LOJEK A, KNOTKOVÁ Z, KOTRBÁČEK V, SCHEER P, HOLEŠOVSKÁ Z 2005: Effect of stilbene resveratrol on haematological indices of rats. Acta Vet Brno 74: 205-208
12. DUNN JS, MCLETCHIE NGB 1943: Experimental alloxan diabetes in the rat. Lancet 1943: 484-487
13. EL-HAGE A, HERMAN EH, YANG GC, CROUCH RK, FERRANS VJ 1986: Mechanism of the protective activity of ICRF-187 against alloxan-induced diabetes in mice. Res Commun Chem Pathol Pharmacol 52: 341-360
14. EL NAGGAR EMB, BARTOŠÍKOVÁ L, ŽEMLIČKA M, ŠVAJDLENKA E, RABIŠKOVÁ M, STRNADOVÁ V, NEČAS J 2005: Antidiabetic effect of Cleome droserifolia aerial parts: Lipid peroxidation-induced oxidative stress in diabetic rats. Acta Vet Brno 74: 347-352
15. FIRUZI O, LACANNA A, PETRUCCI R, MARROSU G, SASO L 2005: Evaluation of the antioxidant activity of flavonoids by "ferric reducing antioxidant power" assay and cyclic voltammetry. Biochim Biophys Acta 1721: 174-184
16. FURUSAWA M, TANAKA T, ITO T, NISHIKAWA A, YAMAZAKI N, NAKAYA K, MATSUURA N, TSUCHYIA H, NAGAYAMA M, IINUMA M 2005: Antioxidant anctivity of hydroxyflavonoids. J Health Sci 51: 376-378
17. HEIKKILA R, WINSTON B, COHEN G 1976: Alloxan induced-diabetes evidence for hydroxyl radical as a cytotoxic intermediate. Biochem Pharmacol 25: 1085-1092
18. HERTOG MG, HOLLMAN PC 1996: Potential health effects of the dietary flavonol quercetin. Eur J Clin Nutr 50: 63-71
19. HONGU M, TANAKA T, FUNAMI N, SAITO K, ARAKAWA K, MATSUMOTO M, TSUJIHARA K. 1998: Na(+)-glucose cotransporter inhibitors as antidiabetic agents. II. Synthesis and structure-activity relationships of 4′-dehydroxyphlorizin derivatives. Chem Pharm Bull (Tokyo) 46: 22-33
20. KARACA T, CEMEK M, KANTER M 2006: Lipid peroxidation and antioxidant levels, and alpha naphthyl acetate esterase activity of peripheral blood lymphocytes in Mallard, Muscovy and Pekin ducks. Acta Vet Brno 75: 33-38
21. KNEKT P, KUMPULAINEN J, JÄRVINEN R, RISSANEN H, HELIÖVAARA M, REUNANEN A, HAKULINEN T, AROMAA A 2002: Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76: 560-568
22. KUBO I, KINST-HORI I, CHAUDHURI SK, KUBO Y, SANCHEZ Y, OGURA T 2000: Flavonols from Heterotheca inuloides: tyrosinase inhibitory activity and structural criteria. Bioorg Med Chem 8: 1749-1755
23. LANKIN VZ, KORCHIN VI, KONOVALOVA GG, LISINA MO, TIKHAZE AK, AKMAEV IG, 2004: Role of antioxidant enzymes and antioxidant compound probucol in antiradical protection of pancreatic beta-cells during alloxan-induced diabetes. Bull Exp Biol Med 137: 20-23
24. MAGHRANI M, MICHEL JB, EDDOUKS M 2005: Hypoglycaemic activity of Retama raetam in rats. Phytother Res 19: 125-128
25. MAHESH T, MENON VP 2004: Quercetin alleviates oxidative stress in streptozotocin-induced diabetic rats. Phytother Res 18: 123-127
26. MARITIM AC, SANDERS RA, WATKINS JBIII 2003: Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17: 24-38
27. MEHTA JL, RASOULI N, SINHA AK, MOLAVI B 2006: Oxidative stress in diabetes: A mechanistic overview of its effects on atherogenesis and myocardial dysfunction. Int J Biochem Cell Biol 38: 794-803
28. MIRA L, FERNANDEZ MT, SANTOS M, ROCHA R, FLORENCIO MH, JENNINGS KR 2002: Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 36: 1199-1208
29. MOJŽIŠOVÁ G, PETRÁŠOVÁ D, KOPROVIČOVÁ J 1999: Flavonoids with antioxidant action and their effect on human health. Slovakofarma Rev 9: 35-37
30. NEWSHOLME P, HABER EP, HIRABARA SM, REBELATO ELO, PROCOPIO J, MORGAN D, OLIVEIRA -EMILIO HC, CARPINELI AR, CURI R 2007: Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 583: 9-24
31. NURALIEV I, AVEZOV GA 1992: The efficacy of quercetin in alloxan diabetes. Eksp Klin Farmakol 55: 42-44
32. OKAMOTO T 2005: Safety of quercetin for clinical application (Review). Int J Mol Med 16: 275-278
33. ROSS JA, KASUM CM 2002: Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22: 19-34
34. SOTO C, MURIEL P, REYES JL 1994: Pancreatic lipid peroxidation in alloxan-induced diabetes mellitus. Arch Med Res 25: 377-380
35. SZKUDELSKI T 2001: The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50: 536-546
36. WINTERBOURN CC, MUNDAY R 1989: Glutathione-mediated redox cycling of alloxan. Mechanisms of superoxide dismutase inhibition and of metal-catalyzed OH formation. Biochem Pharmacol 38: 271-277